Skip to content

EFFICACY OF ARTIFICIAL INTELLIGENCE DRIVEN PROGRAM VERSUS TRADITIONAL PHYSICAL THERAPY PROGRAM IN PATIENTS WITH LOW BACK DYSFUNCTION

Efficacy of an Artificial Intelligence-Driven Program Versus a Traditional Physical Therapy Program in Patients With Low Back Dysfunction

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07749833
Acronym
AI-LBD
Enrollment
68
Registered
2026-08-06
Start date
2026-08-01
Completion date
2027-01-01
Last updated
2026-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Dysfunction, Low Back Pain

Keywords

Artificial Intelligence, Low Back Dysfunction, Low Back Pain, Physical Therapy, Rehabilitation, Exercise Therapy, AI-Driven Rehabilitation, Musculoskeletal Rehabilitation, Randomized Controlled Trial, Personalized Rehabilitation

Brief summary

Low back dysfunction is one of the most common musculoskeletal disorders and is associated with pain, disability, and reduced quality of life. Artificial intelligence (AI) has emerged as a promising tool to support personalized rehabilitation by improving exercise prescription, monitoring adherence, and providing real-time feedback. This randomized controlled trial aims to compare the effectiveness of an AI-driven rehabilitation program with a traditional physical therapy program in patients with low back dysfunction. Primary outcomes include pain intensity, functional disability, and quality of life. The findings may provide evidence regarding the role of AI-assisted rehabilitation in improving clinical outcomes.

Detailed description

This study is a prospective randomized controlled trial designed to evaluate the efficacy of an artificial intelligence-driven rehabilitation program compared with a traditional physical therapy program in patients with low back dysfunction. Eligible participants will be randomly allocated into two groups. The experimental group will receive an AI-driven rehabilitation program, while the control group will receive a standardized traditional physical therapy program. Clinical outcomes will be assessed before and after the intervention using validated outcome measures for pain, functional disability, quality of life, and other variables specified in the study protocol. The study aims to determine whether integrating artificial intelligence into rehabilitation provides superior clinical outcomes compared with conventional physical therapy.

Interventions

OTHERAI-Driven Rehabilitation Program

A personalized rehabilitation program guided by artificial intelligence, including individualized exercise prescription and progression.

OTHERTraditional Physical Therapy Program

A conventional physical therapy rehabilitation program delivered according to the study protocol

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants will be randomly assigned to one of two parallel groups: an AI-driven rehabilitation program or a traditional physical therapy program.

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18-45 years. * Male or female participants. * Clinical diagnosis of low back dysfunction by a physiotherapist or physician. * Symptoms lasting more than 3 months. * Ability to participate in physical therapy or use AI-based rehabilitation tools. * Willingness to comply with the study protocol and provide written informed consent.

Exclusion criteria

* Recent spinal injury or spinal surgery. * Previous spinal surgery within the last 6 months. * Severe neurological disorders (e.g., multiple sclerosis or Parkinson's disease). * Chronic conditions that significantly limit mobility (e.g., advanced arthritis). * Current use of strong opioid analgesics. * Severe psychiatric disorders. * Inability to use or access the required technology for the AI intervention.

Design outcomes

Primary

MeasureTime frameDescription
Pain IntensityBaseline and immediately post intervention 6 weeks of treatment.Pain intensity measured using the Visual Analogue Scale (VAS), a 10-cm self-reported pain scale ranging from 0 (no pain) to 10 (worst imaginable pain).

Secondary

MeasureTime frameDescription
Functional PerformanceBaseline and after 6 weeks.Functional performance measured using the Back Performance Scale (BPS). The total score ranges from 0 to 15, with higher scores indicating greater functional limitation.
Cost-effectivenessAfter completion of the 6-week intervention.Cost-effectiveness assessed using the Incremental Cost-Effectiveness Ratio (ICER), based on total costs and clinical effectiveness of the AI-driven and traditional physical therapy programs,including direct medical costs, intervention-related costs, and healthcare utilization costs.
Lumbar Range of MotionBaseline and after 6 weeks.Lumbar range of motion assessed using the Back Range of Motion (BROM II) device measuring lumbar flexion, extension, lateral flexion, and rotation.

Countries

Egypt

Contacts

CONTACTDalia A Youssef, MSc, PT
Daliayoussef151023@gmail.com+20 101 578 8109

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 8, 2026